The Eukaryotic Tranaslation Initiation Factor 4 E is an important component of the signaling cascade that leads to the initiation of translation. As you can see in the picture below, translation initiation is part of the cascade of PI3K or phosphoinositide 3 kinase, a potent stimulator of cell growth. It is believed to be a proto-oncogene and is elevated in several cancers. It also blocks apoptosis or cell death through downstream regulation of Protein kinase B or PKB.
Elevated PI3K or mTOR can lead to increased expression (and hence activity) of EIF4E, which in turn can lead to increase in tumor size. Control of EIF4E expression is therefore an attractive option in anti-cancer therapy.
Link to figure:
http://www.massgeneral.org/neurology/Reeves/Research Images/mtoract.jpg
In a recent study, the authors used EIF4E specific anti-sense oligonucteotides, which bind to the target EIF4E RNA and mediate its destruction to regulate the amount of EIF4E present.
This had the effect of reducing translation initiation and hence cell growth, reducing the tumors in mice with no apparent side effects.
More.
Elevated PI3K or mTOR can lead to increased expression (and hence activity) of EIF4E, which in turn can lead to increase in tumor size. Control of EIF4E expression is therefore an attractive option in anti-cancer therapy.
Link to figure:
http://www.massgeneral.org/neurology/Reeves/Research Images/mtoract.jpg
In a recent study, the authors used EIF4E specific anti-sense oligonucteotides, which bind to the target EIF4E RNA and mediate its destruction to regulate the amount of EIF4E present.
This had the effect of reducing translation initiation and hence cell growth, reducing the tumors in mice with no apparent side effects.
More.